PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost

Advertisement

A&M Stabtest April 26
Scientific Lab Show
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage
DDL 2026
Volume 8 Issue 1

Building a Patient Centric Supply Chain

Patient well-being should be at the heart of all decisions made within the life sciences. Despite this, other factors often compete for decision-makers' attention an...
Continue Reading →
Volume 8 Issue 1

Breath Analysis in Diagnostics: The Use of Animal Models

Developing breath analysis methodologies in mouse models has significant benefits for clinical research and in practice for a range of therapeutics. Sampling medi...
Continue Reading →
Volume 8 Issue 1

Patient-Derived Xenografts Strengthen Mouse Clinical Trials in Oncology Research

Patient-Derived Xenograft (PDX) mouse models involve implanting human tumour tissues into immunodeficient mice, preserving the original tumour's genetic and histolog...
Continue Reading →
Volume 8 Issue 1

Leveraging Liquid Biopsy to Advance Metastatic Cancer Care

Liquid Biopsy: A Non-Invasive Approach to Tumour Profiling Metastasis is responsible for 90% of cancer-related deaths, yet most treatments focus on primary disease. ...
Continue Reading →
Volume 7 Issue 4

Demonstrating Equivalence Between Recombinant Semaglutide APIs

This article presents a quality comparison between the recombinant origin Semaglutide drug substance made by Aurisco and the innovator’s injectable and oral Semaglut...
Continue Reading →
Editorial Archives

Enzene Talk All Things EnzeneX(TM) 2.0

The goal to find the most efficient, cost effective and sustainable processing technologies continues to be at the forefront of the biopharmaceutical and pharmaceuti...
Continue Reading →
Volume 7 Issue 4

Polypure Celebrates and Reflects on 25 Years in the Pharmaceutical Industry 

Polypure have been at the forefront of developments in the pharmaceutical industry for 25 years, being a driving force for high-quality PEG’s and PEG-derivatives. Ch...
Continue Reading →
Volume 7 Issue 4

Emerging Pharma vs. Big Pharma: Rethinking CRO Partnerships

In today’s competitive pharmaceutical landscape, outsourcing has become essential to the development and commercialisation of drugs. This is especially true for emer...
Continue Reading →
Volume 7 Issue 4

Breath Analysis and Cancer: The Future of Early Detection and Personalised Medicine 

VOCs and Breath  There are many challenges associated with cancer management, including delayed diagnosis, low efficacy of treatment, and heterogeneity of di...
Continue Reading →
Volume 7 Issue 4

In vitro Models Guiding Strategic Decision-making in Biotherapeutic Development

Scientific advancements and evolving regulatory requirements are continually reshaping the drug development process. Navigating the intricacies and financial challen...
Continue Reading →
The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech
PharmExcel